Rochelle E Nasto

Title: Innovations of Rochelle E Nasto

Introduction

Rochelle E Nasto is a prominent inventor based in Washington, DC. She has made significant contributions to the field of cancer research, particularly in developing methods to inhibit the proliferation of estrogen-independent cancer cells. Her work is vital in advancing treatment options for patients facing these challenging conditions.

Latest Patents

Rochelle E Nasto holds 1 patent for her invention titled "Methods of inhibiting proliferation of estrogen-independent cancer cells." This patent relates to innovative methods aimed at reducing the growth or proliferation of specific cancer cells by targeting the expression or activity of various genes. The genes involved in her research include BLOC1S1, CDC2L1, CNOT1, DDX54, EIF3I, FANCG, FBP1, IER2, KIF1A, LCK, NR2F1, PNRC1, POLR2A, POLR2B, POLR2C, PRPF6, PSMB4, PSMC5, PSMD1, RPS2, SCNN1A, SF3A3, TAF2, TOB1, and TSC22D4.

Career Highlights

Rochelle is affiliated with Georgetown University, where she continues her research and innovation in cancer treatment. Her dedication to scientific advancement has positioned her as a key figure in her field.

Collaborations

Throughout her career, Rochelle has collaborated with esteemed colleagues, including Louis M Weiner and Robert R Clarke. These partnerships have enhanced her research and contributed to the development of her innovative methods.

Conclusion

Rochelle E Nasto's work exemplifies the impact of innovation in cancer research. Her contributions are paving the way for new treatment strategies that could significantly improve patient outcomes.